FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1848944651> ?p ?o ?g. }

• W1848944651 abstract "In the Netherlands, 5.6 % of acute hospital admissions are medication-related. Almost half of these admissions are potentially preventable. Reviewing medication in patients at risk in primary care might prevent these hospital admissions. At present, implementation of medication reviews in primary care is suboptimal: pharmacists lack access to patient information, pharmacists are short of clinical knowledge and skills, and working processes of pharmacists (focus on dispensing) and general practitioners (focus on clinical practice) match poorly. Integration of the pharmacist in the primary health care team might improve pharmaceutical care outcomes. The aim of this study is to evaluate the effect of integration of a non-dispensing pharmacist in general practice on the safety of pharmacotherapy in the Netherlands.The POINT study is a non-randomised controlled intervention study with pre-post comparison in an integrated primary care setting. We compare three different models of pharmaceutical care provision in primary care: 1) a non-dispensing pharmacist as an integral member of a primary care team, 2) a pharmacist in a community pharmacy with a predefined training in performing medication reviews and 3) a pharmacist in a community pharmacy (care as usual). In all models, GPs remain accountable for individual medication prescription. In the first model, ten non-dispensing clinical pharmacists are posted in ten primary care practices (including 5 - 10 000 patients each) for a period of 15 months. These non-dispensing pharmacists perform patient consultations, including medication reviews, and share responsibility for the pharmaceutical care provided in the practice. The two other groups consist of ten primary care practices with collaborating pharmacists. The main outcome measurement is the number of medication-related hospital admissions during follow-up. Secondary outcome measurements are potential medication errors, drug burden index and costs. Parallel to this study, a qualitative study is conducted to evaluate the feasibility of introducing a NDP in general practice.As the POINT study is a large-scale intervention study, it should provide evidence as to whether integration of a non-dispensing clinical pharmacist in primary care will result in safer pharmacotherapy. The qualitative study also generates knowledge on the optimal implementation of this model in primary care. Results are expected in 2016.NTR4389 , The Netherlands National Trial Register, 07-01-2014." @default.
• W1848944651 created "2016-06-24" @default.
• W1848944651 creator A5006953234 @default.
• W1848944651 creator A5046456153 @default.
• W1848944651 creator A5048948065 @default.
• W1848944651 creator A5049321682 @default.
• W1848944651 creator A5085241857 @default.
• W1848944651 creator A5086325346 @default.
• W1848944651 creator A5090103426 @default.
• W1848944651 creator A5091739903 @default.
• W1848944651 date "2015-07-02" @default.
• W1848944651 modified "2023-09-27" @default.
• W1848944651 title "Design of the POINT study: Pharmacotherapy Optimisation through Integration of a Non-dispensing pharmacist in a primary care Team (POINT)" @default.
• W1848944651 cites W1493332517 @default.
• W1848944651 cites W186640681 @default.
• W1848944651 cites W1879382242 @default.
• W1848944651 cites W1970632286 @default.
• W1848944651 cites W1970773196 @default.
• W1848944651 cites W2008228624 @default.
• W1848944651 cites W2015476616 @default.
• W1848944651 cites W2020253165 @default.
• W1848944651 cites W2044028841 @default.
• W1848944651 cites W2073987147 @default.
• W1848944651 cites W2093681667 @default.
• W1848944651 cites W2105312421 @default.
• W1848944651 cites W2108701948 @default.
• W1848944651 cites W2126292472 @default.
• W1848944651 cites W2133273092 @default.
• W1848944651 cites W2140717488 @default.
• W1848944651 cites W2159739809 @default.
• W1848944651 cites W2164297140 @default.
• W1848944651 cites W2167100077 @default.
• W1848944651 cites W2320806320 @default.
• W1848944651 cites W4250260862 @default.
• W1848944651 cites W4293202440 @default.
• W1848944651 cites W92417152 @default.
• W1848944651 doi "https://doi.org/10.1186/s12875-015-0296-8" @default.
• W1848944651 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4489035" @default.
• W1848944651 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26135582" @default.
• W1848944651 hasPublicationYear "2015" @default.
• W1848944651 type Work @default.
• W1848944651 sameAs 1848944651 @default.
• W1848944651 citedByCount "21" @default.
• W1848944651 countsByYear W18489446512016 @default.
• W1848944651 countsByYear W18489446512017 @default.
• W1848944651 countsByYear W18489446512018 @default.
• W1848944651 countsByYear W18489446512019 @default.
• W1848944651 countsByYear W18489446512020 @default.
• W1848944651 countsByYear W18489446512021 @default.
• W1848944651 countsByYear W18489446512022 @default.
• W1848944651 crossrefType "journal-article" @default.
• W1848944651 hasAuthorship W1848944651A5006953234 @default.
• W1848944651 hasAuthorship W1848944651A5046456153 @default.
• W1848944651 hasAuthorship W1848944651A5048948065 @default.
• W1848944651 hasAuthorship W1848944651A5049321682 @default.
• W1848944651 hasAuthorship W1848944651A5085241857 @default.
• W1848944651 hasAuthorship W1848944651A5086325346 @default.
• W1848944651 hasAuthorship W1848944651A5090103426 @default.
• W1848944651 hasAuthorship W1848944651A5091739903 @default.
• W1848944651 hasBestOaLocation W18489446511 @default.
• W1848944651 hasConcept C10446079 @default.
• W1848944651 hasConcept C104863432 @default.
• W1848944651 hasConcept C129930760 @default.
• W1848944651 hasConcept C159110408 @default.
• W1848944651 hasConcept C160735492 @default.
• W1848944651 hasConcept C162324750 @default.
• W1848944651 hasConcept C2426938 @default.
• W1848944651 hasConcept C2779457091 @default.
• W1848944651 hasConcept C2780670349 @default.
• W1848944651 hasConcept C2984752397 @default.
• W1848944651 hasConcept C3604424 @default.
• W1848944651 hasConcept C500440147 @default.
• W1848944651 hasConcept C50522688 @default.
• W1848944651 hasConcept C512399662 @default.
• W1848944651 hasConcept C51915194 @default.
• W1848944651 hasConcept C71924100 @default.
• W1848944651 hasConceptScore W1848944651C10446079 @default.
• W1848944651 hasConceptScore W1848944651C104863432 @default.
• W1848944651 hasConceptScore W1848944651C129930760 @default.
• W1848944651 hasConceptScore W1848944651C159110408 @default.
• W1848944651 hasConceptScore W1848944651C160735492 @default.
• W1848944651 hasConceptScore W1848944651C162324750 @default.
• W1848944651 hasConceptScore W1848944651C2426938 @default.
• W1848944651 hasConceptScore W1848944651C2779457091 @default.
• W1848944651 hasConceptScore W1848944651C2780670349 @default.
• W1848944651 hasConceptScore W1848944651C2984752397 @default.
• W1848944651 hasConceptScore W1848944651C3604424 @default.
• W1848944651 hasConceptScore W1848944651C500440147 @default.
• W1848944651 hasConceptScore W1848944651C50522688 @default.
• W1848944651 hasConceptScore W1848944651C512399662 @default.
• W1848944651 hasConceptScore W1848944651C51915194 @default.
• W1848944651 hasConceptScore W1848944651C71924100 @default.
• W1848944651 hasIssue "1" @default.
• W1848944651 hasLocation W18489446511 @default.
• W1848944651 hasLocation W184894465110 @default.
• W1848944651 hasLocation W184894465111 @default.
• W1848944651 hasLocation W18489446512 @default.
• W1848944651 hasLocation W18489446513 @default.
• W1848944651 hasLocation W18489446514 @default.
• W1848944651 hasLocation W18489446515 @default.

• next